Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C

BACKGROUND: The standard of care for HCV Hepatitis is the combination of interferon (IFN) plus Ribavirin. In HIV patients the use of this combination therapy may induce drug interactions, and reduces the adherence to HAART. The aim of this study is to evaluate safety and efficacy of a 48 weeks daily...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bruno, Raffaele, Sacchi, Paolo, Puoti, Massimo, Ciappina, Valentina, Zocchetti, Cristina, Brunetti, Enrico, Maffezzini, Elena, Capelli, Anna, Patruno, Savino FA, Malfitano, Antonello, Filice, Gaetano
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2002
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC128825/
https://ncbi.nlm.nih.gov/pubmed/12199910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-2-17
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky